Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > The ROT in Spectral, a Casual Observation
View:
Post by Gorf79 on Aug 26, 2022 10:13am

The ROT in Spectral, a Casual Observation

At 42 cents PMX is valued at a roughly 97% probability of failure.

Below are the valuations attached to recent news releases:

The Arc Dialysis Deal - Worthless

FDA Breakthrough Designation - Worthless

Department of Veterans Affairs Deal - Worthless

After 20 years of unmitigated failure in properly valuing Spectral isn't it time to expect better... to do better?

There is Rot in Spectral.
Comment by Accountprince on Aug 26, 2022 10:30am
Gorf79 I agree with you completely.  Even if you value PMX at zero (this is only theoretical as I think it's likely worth at least $10 per share right now at this stage of the Tigris trial) - the EAA is completely approved worldwide and valuable.  In terms of Dialco SAMI is approved and SELLING, DIMI is fully approved in Canada and in the US it is fully approved save and except for ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities